| Patient | Sonny Liston |
|---|---|
| Date of birth | 1989-05-08 |
| Identifiers | MRN HR-BX007-SYN; SSN (made up) 000-07-8853 |
| Document date | 2026-08-11 |
| Author | Malcolm Achebe-Whitford, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Sonny Liston is a 37-year-old professional heavyweight boxer with stage 2 hypertension and moderate alcohol use disorder who comes for his yearly preventive visit, three weeks after his four-week review. He takes amlodipine 10 mg and valsartan 160 mg each morning and naltrexone 50 mg each morning, and shows the picture card he keeps in his gym bag. His home readings, which the talking monitor reads out and he leaves on the clinic voice line, average 128/80 mmHg. Since starting naltrexone he has three or four drinks on two evenings a week and none on other days. Mild ankle swelling after long runs in the heat goes by morning. He has had no chest pain, breathlessness or palpitations. He wants to be cleared to fight again this fall. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 37 |
| Blood pressure | Clinic 128/80 mmHg; home average 128/80 mmHg |
| Alcohol | Three or four drinks on two evenings a week on naltrexone |
| Mood | PHQ-2 0 |
| Medicines | Amlodipine 10 mg and valsartan 160 mg; naltrexone 50 mg |
Health risk assessment. Asked aloud by the nurse in a private room, one question at a time, with answers recorded for him; reviewed by Dr. Achebe-Whitford. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good; feels stronger since drinking less |
| Psychosocial | Married; close to his trainer and gym; money is steady from fighting and exhibitions |
| Tobacco | Does not smoke |
| Alcohol and drugs | Drinking reduced on naltrexone; no drug use (DAST-10 0 at intake) |
| Physical activity | Trains six days a week: roadwork, bag work and sparring |
| Nutrition | Large meals; eats out often; cutting down on salted meats and fast food |
| Sleep | Seven to eight hours |
| Driving and injury | Drives himself; wears a seat belt; agreed never to drive after drinking |
| Home safety | No firearms in the home; smoke detector working |
| Health literacy | Prefers spoken explanations and pictures; uses the picture card and leaves his readings on the clinic voice line |
| Dental | No dentist for many years; one back tooth sore when chewing |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, night sweats or weight loss |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Positive | A sore lower back tooth when chewing; no hearing loss |
| Cardiovascular | Positive | Mild ankle swelling after long runs in the heat, gone by morning; no chest pain, palpitations or fainting |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No nausea on naltrexone; no abdominal pain, yellowing or bleeding |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Negative | No shoulder or jaw pain with training |
| Integumentary | Negative | No rashes or sores |
| Neurological | Negative | No headaches, dizziness, numbness or memory problems |
| Psychiatric | Negative | Mood good; PHQ-2 0; no thoughts of suicide |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg and valsartan 160 mg combined oral tablet, one tablet each morning | One tablet each morning | Oral route | 2026-06-23 to 2026-07-21 | completed | S |
| Amlodipine 10 mg and valsartan 160 mg combined oral tablet, one tablet each morning | One tablet each morning | Oral route | 2026-07-21 | active | S |
| Naltrexone 50 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 2026-07-21 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-11 | Body height | 185 | cm | S |
| 2026-08-11 | Body weight | 97.6 | kg | S |
| 2026-08-11 | Body mass index (BMI) [Ratio] | 28.5 | kg/m2 | S |
| 2026-08-11 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-08-11 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-08-11 | Heart rate | 56 | /min | S |
| 2026-08-11 | Respiratory rate | 14 | /min | S |
| 2026-08-11 | Body temperature | 36.6 | Cel | S |
| 2026-08-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-11 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
Vital signs recorded on 2026-08-11; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Powerfully built and well; weight 97.6 kg, BMI 28.5; blood pressure 128/80 mmHg; pulse 56 |
| Eyes | Visual acuity 20/20 each eye by picture chart; fundi with no hypertensive changes |
| Mouth | Large cavity in a lower left molar, tender to tapping; gums otherwise healthy; old healed jaw fracture without deformity |
| Cardiovascular | Regular slow rhythm; no murmur or gallop; trace ankle edema; foot pulses normal |
| Respiratory | Clear to auscultation |
| Abdomen | Soft, non-tender; liver not enlarged |
| Skin | Old scars over both brows; no lesions of concern |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| High blood pressure readings at a first visit (154/98 mmHg, average of two readings with a large cuff), without a diagnosis of hypertension; out-of-office confirmation needed | resolved | confirmed | R03.0 | S — Synthetic presenting finding; resolved into the diagnosis at the consultation visit when ambulatory monitoring confirmed hypertension. |
| Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (daytime average 146/94 mmHg, nighttime 132/84 mmHg), with mild concentric left ventricular hypertrophy on echocardiography and normal kidney function and urine albumin | active | confirmed | I10 | S — Synthetic modern diagnosis; no hypertension is documented in his life. |
| Alcohol use disorder, moderate (four DSM-5-TR criteria: drinking more than intended, unsuccessful efforts to cut down, craving, and continued drinking despite its effect on his training, blood pressure and liver tests); AUDIT 16 | active | confirmed | F10.20 | S — Synthetic modern diagnosis by interview, anchored to the description of heavy drinking; not a historical diagnosis. |
| Personal history of physical abuse in childhood (beaten regularly by his father), with heavy field work from the age of eight | active | confirmed | Z62.810 | S — Synthetic coding of the documented childhood history; physical abuse only. |
| Does not read or write (no schooling as a child); prefers spoken explanations, pictures and demonstrations | active | confirmed | Z55.0 | S — Synthetic coding of the documented literacy, recorded so that care is adapted. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 128/80 mmHg on treatment |
| Lipid screening and statin | Up to date | Total cholesterol 204, HDL 58, LDL 122, triglycerides 120 mg/dL at intake; statin not indicated at 37 with low 10-year risk |
| Prediabetes and type 2 diabetes screening | Up to date | Hemoglobin A1c 5.4% and fasting glucose 92 mg/dL at intake |
| Colorectal cancer screening | Not indicated | Begins at 45 |
| HIV screening | Completed today | Routine one-time screening for ages 15 to 65; consent read aloud |
| Hepatitis C screening | Completed today | One-time screening for all adults |
| Hepatitis B screening | Completed today | Triple panel, recommended once for all adults |
| Depression screening | Completed today | PHQ-2 0, read aloud |
| Unhealthy alcohol use | Completed today | In treatment for moderate alcohol use disorder; drinking reduced |
| Unhealthy drug use | Up to date | DAST-10 0 at intake |
| Tobacco cessation | Not indicated | Does not smoke |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap today; no record of an earlier booster |
| Hepatitis B vaccine | Completed today | Dose 1 of 2 (HepB-CpG) today; dose 2 in one month |
| Influenza vaccine | Due | When this season's vaccine arrives in the fall |
| COVID-19 vaccine | Due | Offered with the influenza vaccine in the fall |
| Dental care | Referred | Community dental clinic for a decayed lower molar |
Immunizations given today: Tdap vaccine; no record of an earlier tetanus booster; Hepatitis B vaccine (HepB-CpG), dose 1 of 2, recommended for all adults 19 to 59 [S]
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); AHRQ Health Literacy Universal Precautions Toolkit, 3rd Edition (2024); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Three-month review in six weeks. Second hepatitis B dose in one month. Dental clinic as booked. Influenza and COVID-19 vaccines in the fall. Next preventive visit in one year. Next scheduled visit 2026-09-22: three-month review: blood pressure, liver tests and drinking on naltrexone. [S]
Brief discussion, read aloud and explained in plain words. He was asked who should speak for him if he were badly hurt in the ring or could not speak for himself; he named a health care agent, recorded in the chart and not named here. He said he would want everything done to recover from an injury. He chose to sign a health care power of attorney after it was read to him in full, with the nurse as witness, and was given an audio copy of what it says. [S]